Patients with binge eating disorder reported significant reductions in symptoms and impairment after receiving cognitive behavioral therapy-guided self-help treatment delivered over the phone by a health coach and assisted by a smartphone app.
CODAC Health Recovery & Wellness Inc. has established a service site with 24-hour access to support for patients with opioid use disorder.
Medicare beneficiaries continue to experience limited access to evidence-based treatment for opioid use disorder, at a time when prescription opioid misuse among older adults remains a major concern.
Christoph U. Correll, MD, discusses the results of the ENLIGHTEN‑2 study, which compared weight gain and cardiometabolic side effects in patients taking olanzapine and patients taking olanzapine plus samidorphan.
A label update for the insomnia drug Belsomra (suvorexant) C-IV adds study findings on its use in treating insomnia in patients with mild-to-moderate Alzheimer’s disease, drugmaker Merck announced.
Researchers have developed a machine learning algorithm that uses electroencephalogram (EEG) data to predict whether a selective serotonin reuptake inhibitor (SSRI) is likely to benefit a patient.